Leukotriene antagonists and a method of use there as
申请人:Eli Lilly and Company
公开号:US04764521A1
公开(公告)日:1988-08-16
This invention provides novel compounds which are leukotriene antagonists, certain novel intermediates to the compounds, formulations of the compounds, and a method of using the compounds for the treatment of conditions characterized by an excessive release of leukotrienes.